Dr. Bilchik Furthers Liver and Pancreatic Cancer Treatments

Dr. Anton Bilchik MD, PhD, FACS, Professor of Surgery , Chief of Medicine and Gastrointestinal Research at the John Wayne Cancer Institute and Co-Founder of the California Oncology Research Institute (CORI), is on the forefront of minimally invasive procedures to help patients manage liver and pancreatic cancer. Through the work of Dr. Bilchik and his colleagues in oncological research, the treatment of these cancers have been significantly improved. This comes as good news to people throughout the United States and around the world who have been diagnosed with liver or pancreatic cancer and are seeking the best in modern medicine for treatment.

As one of the leading experts in the management of liver cancer, Dr. Bilchik regularly collaborates with surgeons at MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Duke University and Johns Hopkins. This has resulted in numerous collaborative publications. His expertise has placed him at the head of the pack of liver cancer treatment, where he performs major liver resections and ablations every week. Many of these are doing using minimally invasive techniques. His unique understanding of the field and use of state-of-the-art equipment has made him well sought after the world over. His patients are rarely transfused, often eat the day after surgery and many return home in a few days.

Likewise, Dr. Bilchik's expertise in gastrointestinal cancers have earned him the recognition of being one of the world's leading experts in treating pancreatic cancer. His proficiency with the latest minimally invasive surgical techniques has provided his patients with less pain and shorter hospital stays. As with people seeking treatments for liver cancer, patients stricken with pancreatic cancer from around the world pursue Dr. Bilchik's advanced surgical procedures and multidisciplinary treatments to help live much longer. "Every cancer patient should be treated with an intention to cure" says Dr Bilchik.

Anton Bilchik is one of the leading figures in modern oncology throughout the world. He has receive many awards and accolades within the United States and internationally, including the distinction of being recognized as one of "America's Top Doctors" by Castle Connolly Medical Ltd.'s and one the top 1% of physicians by his peers in US World News Report. Anderson Cooper recently interviewed him on his popular CNN program as an expert on pancreas cancer. Anton Bilchik MD is dedicated to furthering research into the understanding and treatment of liver and pancreatic cancer and he looks forward to continuing to help patients around the world best deal with these diseases and more.

About Anton Bilchik MD
Dr. Anton Bilchik is an internationally recognized leader in cancer research in surgical oncology and gastrointestinal malignancies. Dr. Bilchik is Professor of Surgery, Chief of Medicine and Gastrointestinal Research at the John Wayne Cancer Institute and co-founder of the California Oncology Research Institute (CORI). He is a pioneer of various surgical approaches for the staging of gastrointestinal cancers and minimally invasive surgeries to combat liver tumors. Dr. Bilchik has been the recipient of many awards and accolades for his accomplishments in the medical community, including the American Cancer Society. He is a member of the American Surgical Association. For more information, visit www.antonbilchikmd.com.